The Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-Analysis.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science

Emigrants and Immigrants* ; Endemic Diseases* ; Refugees*; Hepatitis C/*epidemiology ; Hepatitis C Antibodies/*blood; Adolescent ; Adult ; Humans ; Seroepidemiologic Studies ; Young Adult

Background & Aims: Hepatitis C virus (HCV) infection is a significant global health issue that leads to 350,000 preventable deaths annually due to associated cirrhosis and hepatocellular carcinoma (HCC). Immigrants and refugees (migrants) originating from intermediate/high HCV endemic countries are likely at increased risk for HCV infection due to HCV exposure in their countries of origin. The aim of this study was to estimate the HCV seroprevalence of the migrant population living in low HCV prevalence countries.
Methods: Four electronic databases were searched from database inception until June 17, 2014 for studies reporting the prevalence of HCV antibodies among migrants. Seroprevalence estimates were pooled with a random-effect model and were stratified by age group, region of origin and migration status and a meta-regression was modeled to explore heterogeneity.
Results: Data from 50 studies representing 38,635 migrants from all world regions were included. The overall anti-HCV prevalence (representing previous and current infections) was 1.9% (95% CI, 1.4-2.7%, I2 96.1). Older age and region of origin, particularly Sub-Saharan Africa, Asia, and Eastern Europe were the strongest predictors of HCV seroprevalence. The estimated HCV seroprevalence of migrants from these regions was >2% and is higher than that reported for most host populations.
Conclusion: Adult migrants originating from Asia, Sub-Saharan Africa and Eastern Europe are at increased risk for HCV and may benefit from targeted HCV screening.

Erratum in: PLoS One. 2015;10(12):e0144567. (PMID: 26650678)

Gac Sanit. 2010 Jul-Aug;24(4):288-92. (PMID: 20053479)
BMJ. 2014 Jul 07;348:g3308. (PMID: 25002352)
Dig Dis Sci. 1993 Dec;38(12):2151-5. (PMID: 8261814)
Hepatology. 2014 Jul;60(1):37-45. (PMID: 24677184)
Dig Liver Dis. 2015 Jul;47(7):572-6. (PMID: 25882212)
Hepatology. 2014 Jul;60(1):12-4. (PMID: 24825115)
Stat Methods Med Res. 1993;2(2):121-45. (PMID: 8261254)
BMC Infect Dis. 2010 Jul 20;10:213. (PMID: 20646306)
Med Clin (Barc). 2002 Oct 19;119(13):489-91. (PMID: 12406396)
An Pediatr (Barc). 2006 Jun;64(6):550-6. (PMID: 16792963)
J Hepatol. 2014 Nov;61(1 Suppl):S45-57. (PMID: 25086286)
Stat Med. 2002 Jun 15;21(11):1539-58. (PMID: 12111919)
Pediatrics. 2001 Sep;108(3):608-12. (PMID: 11533325)
Eur J Epidemiol. 1996 Jun;12(3):297-301. (PMID: 8884198)
Wkly Epidemiol Rec. 1999 Dec 10;74(49):425-7. (PMID: 10645164)
Eur J Epidemiol. 1993 Sep;9(5):537-40. (PMID: 8307139)
Infection. 1999 May-Jun;27(3):212-7. (PMID: 10378135)
Liver Int. 2011 Jul;31 Suppl 2:61-80. (PMID: 21651703)
J Hepatol. 2011 Dec;55(6):1207-14. (PMID: 21703202)
Epidemiol Infect. 2000 Aug;125(1):163-7. (PMID: 11057972)
Liver Int. 2011 Jul;31 Suppl 2:30-60. (PMID: 21651702)
Clin Microbiol Infect. 2011 Feb;17(2):107-15. (PMID: 21091831)
Dig Liver Dis. 2010 Jul;42 Suppl 3:S206-14. (PMID: 20547305)
Can Commun Dis Rep. 2014 Dec 18;40(19):429-436. (PMID: 29769874)
J Clin Epidemiol. 2014 Aug;67(8):897-903. (PMID: 24794697)
J Med Econ. 2012;15(5):887-96. (PMID: 22458755)
Ann Intern Med. 2009 Aug 18;151(4):W65-94. (PMID: 19622512)
Eur J Gastroenterol Hepatol. 1995 Jun;7(6):553-8. (PMID: 7552639)
Isr J Med Sci. 1993 Jun-Jul;29(6-7):387-9. (PMID: 8394300)
J Viral Hepat. 2014 May;21 Suppl 1:34-59. (PMID: 24713005)
J Antimicrob Chemother. 2011 Mar;66(3):641-4. (PMID: 21177673)
Med J Aust. 2001 Dec 3-17;175(11-12):600-2. (PMID: 11837856)
Epidemiol Infect. 1998 Aug;121(1):179-83. (PMID: 9747770)
Infection. 2003 Mar;31(2):70-4. (PMID: 12682810)
J Hepatol. 2006 Oct;45(4):529-38. (PMID: 16879891)
PLoS One. 2014 Jun 09;9(6):e99677. (PMID: 24911341)
J Med Virol. 1995 Apr;45(4):429-34. (PMID: 7666043)
Eur J Pediatr. 2009 Sep;168(9):1101-6. (PMID: 19125292)
Eur J Epidemiol. 2001;17(3):263-6. (PMID: 11680545)
J Matern Fetal Neonatal Med. 2004 Aug;16(2):106-10. (PMID: 15512720)
CMAJ. 2011 Sep 6;183(12):E824-925. (PMID: 20530168)
Liver Int. 2014 Nov;34(10):1447-51. (PMID: 24840955)
G Ital Med Lav Ergon. 2007 Jul-Sep;29(3 Suppl):745-7. (PMID: 18409937)
J Viral Hepat. 2013 Aug;20 Suppl 2:1-20. (PMID: 23827008)
Eur J Gen Pract. 2010 Dec;16(4):236-40. (PMID: 20954813)
Ann Intern Med. 2013 Sep 3;159(5):349-57. (PMID: 23798026)
Can Commun Dis Rep. 2007 Dec 1;33(13):16-22. (PMID: 18161207)
Am J Trop Med Hyg. 2013 Apr;88(4):789-94. (PMID: 23339201)
Scand J Infect Dis. 1990;22(5):619-20. (PMID: 2175449)
J Viral Hepat. 2014 May;21 Suppl 1:60-89. (PMID: 24713006)
BMJ. 2015 Mar 16;350:h870. (PMID: 25775931)
Enferm Infecc Microbiol Clin. 2012 Feb;30(2):64-9. (PMID: 22079225)
PLoS One. 2012;7(5):e38194. (PMID: 22693599)
Can J Public Health. 2008 Nov-Dec;99(6):499-504. (PMID: 19149395)
J Med Virol. 2006 Dec;78(12):1599-608. (PMID: 17063510)
Clin Infect Dis. 2012 May;54(9):1259-71. (PMID: 22412061)
Enferm Infecc Microbiol Clin. 2007 Nov;25(9):604. (PMID: 17953904)
Gastroenterol Clin Biol. 1992;16(3):255-9. (PMID: 1582542)
World J Gastroenterol. 2003 May;9(5):993-5. (PMID: 12717844)
Pathol Biol (Paris). 1991 Dec;39(10):991-6. (PMID: 1805141)
J Clin Gastroenterol. 1997 Jan;24(1):30-3. (PMID: 9013347)
J Community Health. 2012 Jun;37(3):547-53. (PMID: 21922163)
Pediatrics. 2000 Jun;105(6):E76. (PMID: 10835089)
Nat Rev Gastroenterol Hepatol. 2013 Sep;10(9):553-62. (PMID: 23817321)
Liver Int. 2011 Jul;31 Suppl 2:18-29. (PMID: 21651701)
Ann Intern Med. 2006 May 16;144(10):705-14. (PMID: 16702586)
Ann Intern Med. 2012 Dec 4;157(11):817-22. (PMID: 22910836)
Stat Med. 2009 Feb 28;28(5):721-38. (PMID: 19072749)
Ann Intern Med. 2012 Feb 21;156(4):263-70. (PMID: 22056542)
Enferm Infecc Microbiol Clin. 2003 Dec;21(10):540-2. (PMID: 14642251)
Ann Intern Med. 2007 Jan 2;146(1):20-4. (PMID: 17200218)
J Clin Gastroenterol. 1997 Dec;25(4):650-2. (PMID: 9451681)
J Infect Dis. 2010 Aug 15;202(4):576-84. (PMID: 20617929)
Therap Adv Gastroenterol. 2015 Sep;8(5):298-312. (PMID: 26327920)
Hepatology. 2013 Apr;57(4):1333-42. (PMID: 23172780)
Travel Med Infect Dis. 2008 Jan-Mar;6(1-2):4-11. (PMID: 18342267)
J Public Health Med. 1994 Mar;16(1):71-8. (PMID: 8037956)
Rev Clin Esp. 2008 Oct;208(9):426-31. (PMID: 19000469)
Int J Infect Dis. 2001;5(4):209-13. (PMID: 11953219)
J Epidemiol Community Health. 2013 Nov 1;67(11):974-8. (PMID: 23963506)
Am J Gastroenterol. 1994 Oct;89(10):1918-9. (PMID: 7942709)
World J Gastroenterol. 2007 May 7;13(17):2436-41. (PMID: 17552026)
J Clin Epidemiol. 2011 Apr;64(4):383-94. (PMID: 21195583)
Pediatr Infect Dis J. 2002 Sep;21(9):830-4. (PMID: 12352804)
Transfusion. 2016 Jan;56(1):203-14. (PMID: 26355711)
Lancet Infect Dis. 2002 May;2(5):293-302. (PMID: 12062995)

0 (Hepatitis C Antibodies)

Date Created: 20151113 Date Completed: 20160613 Latest Revision: 20240327

20240327

PMC4641717

10.1371/journal.pone.0141715

26558905